Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cytokinetics

34.57
-1.4200-3.95%
Pre-market: 35.991.42+4.11%04:12 EDT
Volume:3.28M
Turnover:118.51M
Market Cap:4.09B
PE:-6.57
High:38.77
Open:36.52
Low:34.26
Close:35.99
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h
More
1D
5D
D
W
M
Q
Y
1m
5m
10m
15m
30m
1h
2h

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Nov 2024

Positive Clinical Outcomes Drive Buy Rating for Cytokinetics’s Cardiac Myosin Modulators

TIPRANKS
·
18 Nov 2024

Cytokinetics Presents New Data Relating to Aficamten and Hypertrophic Cardiomyopathy at the American Heart Association Scientific Sessions 2024

THOMSON REUTERS
·
16 Nov 2024

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Cytokinetics’ Promising Future: Buy Rating Backed by Strong Pipeline and Strategic Positioning

TIPRANKS
·
11 Nov 2024

Cytokinetics initiates phase 1 clinical study of muscle troponin activator CK-089

seekingalpha
·
11 Nov 2024

Cytokinetics Doses First Participants in Study of Potential Muscular Dystrophy Treatment

MT Newswires Live
·
11 Nov 2024

BRIEF-Cytokinetics Announces Initiation Of Phase 1 Clinical Study Of CK-4015089

Reuters
·
11 Nov 2024

Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4015089

THOMSON REUTERS
·
11 Nov 2024

Cytokinetics (CYTK) Initiated with a Buy at RBC Capital

TIPRANKS
·
11 Nov 2024

Cytokinetics: Strategic Growth and Strong Financial Positioning Drive Buy Rating

TIPRANKS
·
11 Nov 2024

Cytokinetics started at outperform by RBC, valuation cited

seekingalpha
·
08 Nov 2024

Stock Track | Cytokinetics Soars on Bullish Analyst Coverage

Stock Track
·
08 Nov 2024

RBC Starts Cytokinetics With Outperform Rating, $80 Price Target

MT Newswires Live
·
08 Nov 2024

Cytokinetics Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
08 Nov 2024

Cytokinetics Initiated at Outperform by RBC Capital

Dow Jones
·
08 Nov 2024

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Artivion (AORT) and RxSight (RXST)

TIPRANKS
·
08 Nov 2024

Cytokinetics Price Target Maintained With a $120.00/Share by HC Wainwright & Co.

Dow Jones
·
07 Nov 2024

Cytokinetics Q3 Loss Widens, Revenue Rises

MT Newswires Live
·
07 Nov 2024

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS), Sarepta Therapeutics (SRPT) and Cytokinetics (CYTK)

TIPRANKS
·
07 Nov 2024

If the download button clicks without skipping, click on the top right menu and select "Open in Browser."